BridgeBio is demonstrably advanced the progress of a novel solution for amyloid heart disease, employing the investigational drug. Initial clinical data reveals promising improvements for patients affected with this serious disease. The focus highlights the company’s focus to treating critical healthcare needs in a cardiology field. Att… Read More